Showing results (131-140 of 435) with videos related to
Sort By:
Pageof 44
Blood|May 15, 1997
Use of partially mismatched related donors extends access to allogeneic marrow transplantP J Henslee-Downey, S H Abhyankar, R S Parrish, et al.Cytotherapy|June 25, 2008
A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy productsA P Gee, D Sumstad, J Stanson, et al.Bone Marrow Transplantation|April 16, 1998
Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donorsL S Lamb, A P Gee, P J Henslee-Downey, et al.Cytotherapy|September 15, 2009
Influence of T cell depletion method on circulating gammadelta T cell reconstitution and potential role in the graft-versus-leukemia effectL S Lamb, A P Gee, L J Hazlett, et al.Blood|November 16, 2004
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytesKarin C M Straathof, Catherine M Bollard, Uday Popat, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.Transfusion|January 28, 2009
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapiesWilliam Reed, Stephen J Noga, Adrian P Gee, et al.Science Translational Medicine|June 27, 2014
Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCTAnastasia Papadopoulou, Ulrike Gerdemann, Usha L Katari, et al.Pageof 44